• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Virtual Radiologic founder hatches new venture fund

Virtual Radiologic founder hatches new venture fund

October 25, 2010 By MedCity News

MedCity News logo

Dr. Sean Casey, a founder and former CEO of Virtual Radiologic Corp., launched a new early stage venture fund, MedCity News has learned.

Bloomington, Minn.-based Omphalos Venture Partners is targeting healthcare, consumer and information technology companies — Omphalos means central, or focal, point.

Casey, a radiologist who graduated from Johns Hopkins University and Albert Einstein College of Medicine at Yeshiva University, founded Virtual Radiologic in 1999.

Using high-speed broadband connections and a proprietary software system, Virtual’s technology enables short-staffed emergency rooms to outsource “image reads” to radiologists around the country working out of offices or their homes.

Virtual Radiologic went public in 2007 and grew annual sales from $86 million to $121 million last year.

Dr. Casey did not leave Virtual Radiologic on good terms. Rob Kill replaced Casey as CEO in January 2009 in a planned succession, and Casey remained chairman.

However, less than three months later, Virtual said in its proxy statement that its board removed Casey as chairman and decided not to recommend him for re-election “based upon considerations of board size, board relationships and functionality, board composition and the desire to have Mr. Kill elected as a director.”

Still, Casey didn’t walk away empty handed. He remained the company’s second largest shareholder with 3.9 million shares, or 24 percent of Virtual Radiologic.

That means Providence Equity Partners’ $294 million buyout of Virtual Radiologic in July netted Casey around $68 million — a nice chunk of change from which to launch an angel fund. Joining Casey at Omphalos is Mark Marlow, a former CFO at Virtual Radiologic.

The Minnesota Dept. of Employment and Economic Development recently certified Omphalos to receive the angel investment tax credit.

So far, DEED has certified Twin Cities Angels II, Ninety-Seven Twenty-Three LLC and Wildwood Investors. That suggests the angel credit, at least on paper, is helping to create new angel money in town as opposed to just helping people who were going to invest anyway.

Omphalos didn’t immediately return a phone call regarding questions about how much money it is trying to raise.

Filed Under: Uncategorized

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy